Today, a Director at Cambrex (CBM), Louis Grabowsky, bought shares of CBM for $391.5K.
Following Louis Grabowsky’s last CBM Buy transaction on March 16, 2016, the stock climbed by 19.3%. In addition to Louis Grabowsky, 10 other CBM executives reported Buy trades in the last month.
See today’s analyst top recommended stocks >>
Based on Cambrex’s latest earnings report for the quarter ending September 30, the company posted quarterly revenue of $149 million and quarterly net profit of $9.55 million. In comparison, last year the company earned revenue of $105 million and had a net profit of $26.73 million. The company has a one-year high of $60.29 and a one-year low of $33.80. Currently, Cambrex has an average volume of 423.21K.
Louis Grabowsky’s trades have generated a 8.9% average return based on past transactions. DailyInsider proprietary algorithm detects trades by the most influential insiders and selects attractive trading opportunities daily. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Cambrex Corp. engages in the provision of products, services, and technologies to accelerate and improve the development and commercialization of new and generic therapeutics. It supplies to innovator and generic pharmaceutical companies.
